oxidase inhibitors. A recent review4 confirms the existence of such patients but urges that they should be included in the same category as depressive disorder-especially now that the American Psychiatric Association uses "atypical depression" as a residual category. 2 In practical terms, symptom profiles can be more useful in predicting response to monoamine oxidase inhibitors. "Nonendogenicity" is the salient feature. Responders tend to be women more than men and under the age of 40, mood is depressed but retains its reactivity, somatic anxiety features are common, and psychomotor retardation is absent. The patients have lost interest and energy, then show irritability and hypersomnia or initial rather than late insomnia, they have evening worsening of mood, and often they overeat. They do not show guilt, delusional ideas, severe loss of weight, or suicidal intent, and these patients are not usually admitted to hospital. In one subgroup the prominent features are phobias, panic attacks, and depersonalisation.
Clearly these characteristics of the group of patients responsive to monoamine oxidase inhibitors place them at the end of any endogenous-neurotic continuum. The danger is that all that is not psychotic will be treated with these drugs. Careful selection and matching of drug. and patient profiles. are important if treatment is to be successful.
One further question remains. Even if a group of responders to monoamine oxidase inhibitors can be identified, given that the risk of suicide or hospital admission is low and that disability tends to be a result of chronicity rather than of severity, should these dangerous drugs be used ? A formidable list of food and drug incompatibilities must be provided for .the patient, and foods with a high tyramine content must be avoided even if these produce no symptoms.7 The risk of hypertensive crisis is five times higher with tranylcypromine than with phenelzine, and since tranylcypromine is partly metabolised to amphetamine it should never be followed by another monoamine oxidase inhibitor without a washout period.
Given reasonable caution, however, the risk of serious side effects is low, so that the use of monoamine oxidase inhibitor drugs is justifiable in patients with substantial disability who fulfil the diagnostic criteria. Recent work8 suggests that the simultaneous prescription of amitriptyline may significantly reduce sensitivity to tyramine, and such combined antidepressant treatment may prove both safe and effective in patients otherwise resistant to treatment. 4 The prevalence of microscopic haematuria has been documented better in children than in adults. One of the best studies reported microscopic haematuria in 40/ of children. Renal biopsies were done in 23 of the 27 children in whom microscopic haematuria persisted, and 13 were found to have clinically significant lesions.5 Larcom and Carter6 found more than two erythrocytes per high-power field in 1-2% of 3000 young men, and a study from Singapore reported more than five erythrocytes per high-power field in 1 *5% of 67 695 Army recruits.7 This study erifphasised the frequency ofglomerulonephritis, which was detected in 9300 of the 121 recruits who consented to renal biopsy. Eight of these developed renal failure in only three years-glomerulonephritis may prove as "malignant" as cancer-.8
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In 1979 Birch and Fairley9 described a method for examining erythrocytes in the urine and differentiating those coming from the glomerulus from those produced by non-glomerular disease. More recently, they have illustrated the changes in more detail'0 and carried out a blind evaluation ofurine findings in 112 patients with haematuria."1 This analysis shows a high degree of sensitivity (990 %) and specificity (930/,) for diagnosing glomerular bleeding. In non-glomerular bleeding the sensitivity of the test was 100% and the specificity 9000; in other words, no tumours would have been missed.
These studies show that simple observations of the morphological features of erythrocytes in urine permit the expert to diagnose the site of urinary bleeding with a high degree of accuracy. One of the beauties of the method is its simplicity. It requires only a urine specimen, a phase-contrast microscope, and a counting chamber, and must be preferred to invasive procedures claimed to distinguish upper-tract from lowertract bleeding.'2 Erythrocytes that arise from glomeruli show great variation in size, shape, and haemoglobin content, whereas those coming from lesions such as infection, calculi, tumours, and other non-glomerular sources are uniform in size and shape and usually retain a high haemoglobin content (except when the urine is strongly acid).
It is surprising that the importance of these changes has been overlooked for so long. Addis Red cells are present in normal urine. Birch and Fairley found that these red cells are glomerular in type and that 9500 of healthy people have a urinary erythrocyte count below 8 x 106/1.11 This contrasts with the figure of 1 2 x 106/1, which is derived from Addis's studies13 and which we confirm as the upper limit of normal using bright-field microscopy. This difference reflects the many dysmorphic red cells which are overlooked without the better definition given by phasecontrast microscopy. Electron microscopy confirms that these distorted and fragmented structures are indeed erythrocytes."
Though early studies had documented casts in the urine after exercise,'9-2' recent research has focused attention on the bladder as the source of exercise haematuria. Urologists have described lesions of the bladder22 23 and attribute haematuria after exercise to impaction of the flaccid posterior wall of the bladder agains't the base of the bladder during running. A study of marathon runners by' Siegel et a124 has been widely quoted as further evidence that exercise haematuria is not renal. They found haematuria in nine of 50 men (all doctors) after a 42 km run but found no casts. On this basis they advised that patients should be spared expensive invasive testing for exercise-related haematuria but thought that the appearance of casts after running indicated the need for further investigations. Predictably this advice occasioned some comment from traditionalists, who advocate radiographic and endoscopic examination in all those who present with exerciserelated haematuria.25 A leading article' in the BMJ also took a conservative, cautious view.
A study27 using the new methods described above has recently reported the urine findings in 48 people before and after a long-distance run and has given results quite different from those of Siegel et al. 24 Urine samples were examined by doctors and technicians experienced in interpreting redcell morphology, and they found an appreciable rise in the count of glomerular red cells in the urine in 44 of the 48 runners. Counts exceeded the normal range in 33; 46 showed an increase in hyaline and granular casts, and 10 showed red-cell casts after exercise. The red-cell morphology in all indicated a glomerular source for the haematuria.
The differences between these findings and those of Siegel et a124 are not easily explained. Many years ago Alyea and Parish20 showed that the more prolonged the exercise the greater the urinary abnormalities, so the study by Siegel et al is puzzling in showing no casts after a 42 km marathon whereas casts were present in 95% of specimens after a 9 or 14 km run.
We can assume only that the use of phase-contrast microscopy and quantitative counts explains the differences between the two studies (casts are much better defined by phase-contrast microscopy).26
These latest results seem to establish that the glomeruli are the usual source ofhaematuria after exercise. The abnormalities disappear within 24-48 hours, so they seem unlikely to give rise to cumulative damage as Alyea and Parish20 feared, and runners who present with this problem probably require no more than a careful examination of the urine repeated after Recent studies have shown that clinical hypersensitivity to tartrazine may be associated with a humoral immune response to part of the molecule-namely, its sulphophenyl antigenic determinants.7 The antibodies were of the immunoglobulin IgD class, which suggests that immunological mechanisms other than those usually concerned in drug and food allergy play a part in hypersensitivity responses to additives. Additional evidence suggests that the clinical symptoms of intolerance to acetylsalicylic acid and tartrazine are probably not mediated-by antibodies of the IgE class. 8 The important mechanism behind the observed adverse response to aspirin is thought to be inhibition of prostaglandin-synthesising enzymes'°11; and the sensitivity of patients showing abnormal reactions to acetylsalicylic acid extends to other non-steroidal anti-inflammatory drugs and correlates with the ability of the drug concerned to inhibit prostaglandin synthesis.'2 Possibly both the generation and effector function of suppressor cells may be modulated by prostaglandin inhibitors.'3 Though patients have similar pathological reactions to tartrazine and acetylsalicylic acid, however, no effect of tartrazine on inhibition of prostaglandin pathways has been observed,lab indicating that different biological pathways are concerned.
In practical terms, depending on the test protocol followed,14-'6 between 10% and 4000 of patients sensitive to aspirin respond to tartrazine, with reactions ranging from systemic anaphylaxis and severe asthma to urticaria and mild rhinitis. Medical practitioners need to know which drugs contain this dye so that they do not prescribe them for their aspirin-sensitive patients. The prevalence of tartrazine sensitivity is not known but figures of 1 in 10 000 have been suggested7 -remarkably low, given the exposure. Several cases have been reported where the only possible source was a soft drink,18 and other people may have been adversely affected by tartrazine in foods. The incidence of tartrazine sensitivity appears to be higher in asthmatic or allergic subjects than in the general population.'9 Subjects hypersensitive to one substance tend to be allergic to a variety of substances, which again suggests a difference in the general regulation of immune responses. People sensitive to acetylsalicylic acid who are allergic to foods20 should avoid tartrazine as a food dye.
The mechanism of the adverse reaction to tartrazine is not known. Existing tests are largely of low predictive value, and new methods to detect such reactions need to be investigated. Further research is needed into basic mechanisms and, if feasible, the epidemiology of the conditions provoked by tartrazine and corresponding agents to provide reliable data on the number of allergic responses associated with them. Only then can the hazard of tartrazine be properly evaluated. 
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